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Mitochondria are signaling hubs in cellular physiology
that play a role in inflammatory diseases. We found
that partial inhibition of the mitochondrial ATP syn-
thase in the intestine of transgenic mice triggers an
anti-inflammatory response through NFkB activation
mediated by mitochondrial mtROS. This shielding
phenotype is revealed when mice are challenged by
DSS-induced colitis, which, in control animals, trig-
gers inflammation, recruitment of M1 pro-inflamma-
torymacrophages, and the activationof thepro-onco-
genic STAT3 and Akt/mTOR pathways. In contrast,
transgenic mice can polarize macrophages to the M2
anti-inflammatory phenotype. Using the mitochon-
dria-targeted antioxidant MitoQ to quench mtROS
in vivo, we observe decreased NFkB activation, pre-
venting its cellular protective effects. These findings
stress the relevance of mitochondrial signaling to the
innate immune system and emphasize the potential
role of the ATP synthase as a therapeutic target in in-
flammatory and other related diseases.
INTRODUCTION
Mitochondria are vital hubs in cellular physiology, playing essen-
tial roles in the control of energy production, intermediary meta-
bolism, progression through the cell cycle, the execution of cell
death, and signaling. The organelles have established pathways
of communication with the nucleus and with other subcellular
compartments to adapt cellular responses to different cues
(Chandel, 2015; Quiro´s et al., 2016; Shadel and Horvath, 2015).
This communication is exerted by a growing list of signaling mol-
ecules that include Ca2+, various metabolites, and reactive oxy-
gen species (ROS) (Glancy and Balaban, 2012; Sena and Chan-
del, 2012; Shi and Tu, 2015). Defective mitochondria have been1202 Cell Reports 19, 1202–1213, May 9, 2017 ª 2017 The Author(s)
This is an open access article under the CC BY-NC-ND license (http://implicated in inflammatory pathologies such as type 2 diabetes,
Crohn’s disease, and colon cancer (Galluzzi et al., 2012; Naik
and Dixit, 2011; Weinberg et al., 2015). Inflammatory diseases
are often characterized by excessive ROS production (Myant
et al., 2013). Mitochondrial ROS (mtROS) have been suggested
to act as signal-transducing molecules that trigger inflammation
by driving pro-inflammatory cytokine production (Naik and Dixit,
2011). Indeed, mtROS and other metabolites derived from mito-
chondrial activity are critical elements for innate and adaptive im-
mune responses (Colegio et al., 2014; O’Neill, 2014; Osborn and
Olefsky, 2012; Weinberg et al., 2015; West et al., 2015).
ThemitochondrialH+-ATPsynthase is the rotatoryengineof the
inner mitochondrial membrane that utilizes the proton electro-
chemical potential generated by the respiratory chain for the syn-
thesis of ATP (Boyer, 1997). The activity of theH+-ATPsynthase is
regulatedby its physiological inhibitor, theATPase Inhibitory Fac-
tor 1 (IF1). IF1 is known to block rotatory catalysis of the enzyme
when mitochondria become depolarized (Gledhill et al., 2007).
The interaction and inhibitory activity of IF1 on the ATP synthase
is prevented by phosphorylation of S39 in IF1 by the action of
a mitochondrial cyclic AMP (cAMP)-dependent protein kinase
A (PKA) (Garcı´a-Bermu´dez et al., 2015). The overexpression of
IF1, both in cell lines (Formentini et al., 2012; Sa´nchez-Arago´
et al., 2013; Sa´nchez-Cenizo et al., 2010) and in hepatocytes
(Santacatterina et al., 2016) and neurons (Formentini et al.,
2014) of transgenic mice in vivo, also triggers the inhibition of
the synthase by the overloading of the cells with the inhibitor.
The inhibitionof theATPsynthaseby IF1 results in amildROSpro-
duction that acts as a retrograde signal to the nucleus for the acti-
vationofdifferent survival pathways (Formentini et al., 2012,2014;
Santacatterina et al., 2016). The availability of conditional trans-
genic mice that express human IF1 (hIF1) in a tissue-restricted
way (Formentini et al., 2014; Santacatterina et al., 2016) provided
the opportunity to test in vivo the relevance of the inhibition of the
ATP synthase in inflammation and the immune response.
Herein, we have generated a mouse model expressing hIF1
in the intestinal epithelium to assess the physiological role of
the ATP synthase in inflammation. The expression of hIF1.
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Characterization of Mice Express-
ing IF1 in Colon
(A) Western blots reveal the differential expression
of mouse IF1 (12 kDa) in fractionated proteins from
jejunum, ileum, cecum, colon, and rectum extracts.
b-F1-ATPase (bF1) expression is shown as loading
control. mAb, monoclonal antibody.
(B) Western blots of b-F1 and human IF1 in control
(CL) and I/T mice.
(C) Immunohistochemistry reveals the granular
cytoplasmic staining of human IF1 only in colons of
I/Tmice. b-F1 staining in control (CL) and I/Tmice is
also shown. Scale bar, 50 mm.
(D) Hydrolase activity of the ATP synthase in iso-
lated colonocytes from control (CL, black trace)
and I/T (gray trace) mice. Where indicated, 10 mM
oligomycin (OL) was added. Histograms show the
activity in colonocytes from control (CL, closed bar)
and I/T (open bar) mice.
(E) Representative blots of mitochondrial proteins
NADH9 (subunit of complex I), SDHB (subunit of
complex II), COREII (subunit of complex III), COXIV
(subunit of complex IV), and b-F1 (subunit of
complex V) in control (CL) and I/T mice. Two colon
samples per condition tested are shown. HSP60
and VDAC are shown as loading controls.
(F and G) Shown here, (F) cytochrome c oxidase
activity and (G) ATP levels in isolated colonocytes
from control (CL, closed bar) and I/T (open bar)
mice.
(H) Blots of signaling kinases (phosphorylated
[p]-AMPK, AMPK, p-p38, p38, p-AKT, and AKT) in
colon extracts from control (CL) and I/T mice. Two
colon samples per condition tested are presented.
hIF1 is only expressed in I/T mice. b-actin is used
as loading control.
In (D–H), histograms indicate the mean ± SEM of
five mice per group assayed in duplicate. *p < 0.05,
when compared to control by Student’s t test.
See also Figure S5.inhibits the activity of oxidative phosphorylation (OXPHOS),
mediates the shift of colonocytes to an enhanced glycolysis,
and prompts the stimulation of innate immunity through the
activation of the AMPK (50 AMP-activated protein kinase)
pathway and the mtROS-mediated induction of nuclear factor
kB (NFkB) signaling. This metabolic reprogramming affords pro-
tection against dextran sodium sulfate (DSS)-induced intestinal
inflammation and is associated with the recruitment and polari-
zation of intestinal macrophages to the M2 anti-inflammatory
phenotype, a reduction in the production of pro-inflammatory
cytokines, and a diminished tissue activation of mTOR (mamma-
lian target of rapamycin) signaling. Overall, our findings provide
in vivo evidence highlighting the H+-ATP synthase as a target
to prevent inflammation.
RESULTS
The Double-Transgenic I/T Mice Express hIF1 in the
Intestine
Toassess the in vivo role of IF1 in the intestinal epithelium, a trans-
genic Tet-On mouse model was developed. The endogenous
expression of IF1 in mice intestine is variable (Figure 1A), beinghigh in cecum, intermediate in colon, and negligible in ileum (Fig-
ure 1A). Double-transgenic mice (specifically, I/T mice) express-
ing hIF1 were obtained by breeding mice containing the human
Tet-IF1-47 transgene (I) with mice expressing the intestine-spe-
cific Villin-rtTA2-M2 transactivator (T) (Roth et al., 2009). Western
blotting (Figure 1B) and immunohistochemistry (Figure 1C) with a
human-specific anti-IF1 antibody confirmed the expression of
hIF1 in colon in response to the administration of doxycycline.
Expression of hIF1 promoted a significant reduction in the
ATPase activity (Figure 1D) but had no effect on the expression
of several OXPHOS proteins (Figure 1E), with the exception of
an increase in SDHB of complex II (Figure 1E). Interestingly, the
expression of hIF1 in the intestine did not affect the activity of
complex IV of the respiratory chain (Figure 1F). Consistent with
hIF1 exerting a milder inhibition of the ATP synthase than H49K
in vivo, we noted that I/T mice showed no relevant differences in
the content of ATP in the intestine when compared to controls
(Figure 1G). Likewise, none of the stress kinases induced by re-
straining the activity of the ATP synthase with H49K in liver and
in brain (AMPK, p38 MAPK [mitogen-activated protein kinase],
and Akt) (Formentini et al., 2014; Santacatterina et al., 2016)
were affectedby theexpressionofhIF1 in the intestine (Figure1H).Cell Reports 19, 1202–1213, May 9, 2017 1203
Figure 2. Expression of hIF1 Triggers Meta-
bolic Reprogramming
(A) Western blots show the IF1-dependent increase
in the glycolytic proteins LDH-A and GAPDH in two
colon samples per condition tested. PKM1 and
b-actin expression are also shown.
(B) Blots show the enrichment of b-catenin and
impoverishment of vimentin and the CD4 (immune
cell) marker in isolated colonocyte preparations.
Immunofluorescence microscopy of colonocytes
stained with anti-b-catenin (epithelial marker,
green) and anti-vimentin (mesenchymal marker,
red) antibodies. TOPRO staining (blue) identified
nuclei. Scale bar, 20 mm.
(C) Polarographic determination of oxygen con-
sumption rates in isolated colonocytes of control
(CL, closed bars) and I/T (open bars) mice. The
basal, oligomycin (OL)-sensitive (OSR) and FCCP-
stimulated respiration are shown.
(D) Determination of lactate production in colono-
cytes of control (CL, closed bars) and I/T (open
bars) mice. Where indicated, 10 mM OL (gray bar)
was added.
(E) Representative blot of the extent of carbonyla-
tion of total colon proteins. Two different samples
per condition tested are shown. Protein loading of
the samples was verified by western blotting with
anti-tubulin antibody. The migration of molecular
mass markers is indicated at the left. Arrows (at the
right) identify themigration of the two proteins used
in the quantification of protein carbonylation (p-40
and p-80 in histograms). The expression of cata-
lase (Cat), SOD2, p-IkBa, and IkBa and the quan-
tification of the p-IkBa/IkBa ratio are also shown.
(F) Glutathione levels in colon extracts from control
(CL, closed bar) and I/T (open bar) mice. Bars
represent the ratio between reduced and oxidized
forms of gluthatione.
(G) Histograms show theMitoP/MitoB ratio in colon
from control (CL, closed bar) and I/T (open bar)
mice treated or not treated with the mtROS scav-
enger MitoQ (MQ).
(H) Plasma levels of cytokines in CL (closed bars) and I/T (open bars) mice.
In (A–G), histograms indicate the mean ± SEM of five mice per group assayed in duplicate. *p < 0.05, when compared to control by Student’s t test.
See also Figure S1A and Table S1.Metabolic Preconditioning of I/T Mice
In any case, the IF1-mediated inhibition of the H+-ATP synthase
in vivo (Figure 1D) was able to induce metabolic reprogramming
of the intestine to an enhanced glycolysis, as revealed by the
increased expression of the glycolytic proteins LDH-A and
GAPDH (Figure 2A) anddata obtained in isolatedprimary cultures
of colonic crypts (Figures 2B–2D). Indeed, and consistent with
hIF1 inhibiting the ATP synthase in vivo, colonocytes derived
from I/T mice (Figure 2B) presented a reduction in basal and
oligomycin-sensitive respirationwhencompared to controls (Fig-
ure 2C), in the absence of any effect on maximal respiration (Fig-
ure 2C). Accordingly, I/T colonocytes presented an enhanced
glycolysis (Figure 2D) that mimicked the effect of the addition of
oligomycin (Figure 2D).
The inhibition of the H+-ATP synthase by IF1 is known to pro-
mote mtROS signaling—both in vivo (Formentini et al., 2014;
Santacatterina et al., 2016) and in cells in culture (Formentini
et al., 2012; Sa´nchez-Arago´ et al., 2013)—and the subsequent1204 Cell Reports 19, 1202–1213, May 9, 2017preferential carbonylation of proteins in mitochondria (Fig-
ure S1A). Consistently, I/T mice presented enhanced carbonyla-
tion of intestinal proteins when compared to littermate controls
(Figure 2E). While this is consistent with the generation of mtROS
in I/T mice, any such changes were mild, because they did not
modify the cellular GSH/GSSG ratio (Figure 2F) and did not
activate the expression of SOD2 and catalase (Figure 2E).
Consistently, non-significant differences in steady-state levels
of mitochondrial hydrogen peroxide were observed in the colons
of I/T mice using the exomarker approach (Logan et al., 2014)
(Figure 2G). However, activation of the canonical NFkB pathway
was shown as the phosphorylation-dependent degradation of its
inhibitor IkBa (Figure 2E) (Formentini et al., 2012). Consistent
with the activation of the NFkB pathway in the colons of I/T
mice, we observed an increase in plasma of interleukin (IL)-6
when compared to controls (Figure 2H). However, we also noted
that I/T mice showed significantly lower plasma levels of other
pro-inflammatory cytokines, such as IL-1a, IL-1b and G-CSF
Figure 3. IF1 Expression Protects Colon
from DSS-Induced Inflammation
(A) Animal weight is indicated in control (CL, dark
and light blue lines) and I/T (red and orange lines)
mice at the indicated times after the oral adminis-
tration of 2% DSS.
(B and C) Histograms show the intestinal bleeding
score (B) and colon length (C) in CL (closed bars)
and I/T (open bars) mice treated or not treated with
2% DSS during 10 days.
(D) Immunohistochemistry and immunofluores-
cence microscopy of colons from control (CL) and
I/T mice treated or not treated with 2% DSS during
10 days. Colon slices were stained with H&E (first
column), anti-IF1 (second column), TUNEL (third
column), and anti-active caspase-3 (fourth col-
umn). Scale bars, 50 mm.
Histograms show the quantification of the histo-
logic changes score and TUNEL- and active-cas-
pase-3-positive areas in colon slices from CL
(closed bars) and I/T (open bars) mice. Histograms
indicate the mean ± SEM of six mice per group.
*p < 0.05, when compared toCL by Student’s t test;
#p < 0.05, when compared to CL+DSS by Stu-
dent’s t test.
See also Figures S1B–S1D.(granulocyte colony-stimulating factor) (Figure 2H), concurrently
with the enhanced plasma expression of the anti-inflammatory
cytokine IL-10 (Figure 2H). Expression analysis of markers of im-
mune cell populations, cytokines, and other immune-regulatory
and NFkB target genes in the colons of control and I/T mice sup-
ported the anti-inflammatory phenotype of I/T mice (Table S1),
confirming the enhanced expression of IL-10 and reduction of
the pro-inflammatory IL-1b, IL-12, IL-17, and tumor necrosis fac-
tor a (TNF-a) (Table S1), thus suggesting that the activation of the
NFkB pathway by changes in mitochondrial activity could act as
an anti-inflammatory signal in the intestine.
Anti-inflammatory Phenotype of I/T Mice
To investigate this possibility, we followed a standard protocol of
DSS-induced colitis (Wirtz et al., 2007). Administration of DSS toCellthe mice induced extensive oxidative
damage, as revealed by the nitrosylation
and malondialdehyde modification of
colon proteins (Figures S1B and S1C).
Remarkably, colon extracts of I/T mice
experienced less overall oxidative damage
than those of controls (Figures S1B and
S1C). Consistently, the expression of the
transgene significantly reduced the loss in
body weight induced by DSS treatment
(Figure 3A), partially preventing the inflam-
mation-dependent intestinal bleeding (Fig-
ure 3B) and the reduction in colon length
(Figure 3C) when compared to controls.
The histological change score, as as-
sessed in H&E-stained sections (Wirtz
et al., 2007) (Figure 3D), revealed a signifi-cant reduction in I/T mice, indicating that the IF1-mediated inhibi-
tion of the ATP synthase confers protection to the colonic epithe-
lium from DSS-induced damage. Accordingly, the estimation of
cell death by TUNEL or activated caspase-3 was significantly
augmented after 10 days of DSS treatment in control when
compared to I/Tmice (Figure 3D). These findings suggest that pre-
conditioningaffordedby theoverexpressionofhIF1 in the intestine
providesprotectionagainst inducedcolitis. In agreementwithpre-
vious findings regarding preconditioning in the liver (Santacatter-
ina et al., 2016), we observed a significant induction of Nrf-2 in
the colons of I/T mice after DSS administration (Figure S1D).
Signaling the Anti-inflammatory Phenotype
The administration of DSS promoted a stress response in the
colons of control and I/T mice, as revealed by the induction ofReports 19, 1202–1213, May 9, 2017 1205
Figure 4. IF1-Mediated Signaling in
Response to DSS-Induced Inflammation
(A) Blots show the expression of the stress kinase
TRIB3; the metabolic sensor AMPK and p-AMPK;
the phosphorylation of AKT (p-AKT) and of pro-
teins of the mTOR pathway (p-mTOR, p-Raptor,
p-P70S6K, p-4EBP1, and eIF4E); the anti-
apoptotic proteins Bcl-xL, Mcl-1, and Bcl2 and of
the autophagy p62 marker.
(B) Same as above showing the phosphorylation of
IkBa (p-IkBa) and of STAT3 (p-STAT3); the angio-
genic CD31, and invasive CD14 markers in colon
extracts from control (CL) and I/T mice before and
after 10 days of 2% DSS treatment.
In (A) and (B), one sample of non-treated CL and
two different samples of CL and I/T mice after DSS
administration are shown. b-actin expression is
shown as loading control. Histograms indicate the
mean ± SEM of six mice per group and show the
relative expression of the indicated protein or ratio
referred to control non-treated (CL) or DSS-treated
control (CL) and I/T mice. *p < 0.05, when
compared to CL; #p < 0.05, when compared to
DSS-treated CL + DSS by Student’s t test,
respectively.
See also Figure S2.the stress kinases TRIB3 and Akt (Figure 4A). However, this
response was less pronounced in mice overexpressing hIF1
(Figure 4A). Interestingly, I/T mice, but not control mice,
activated the metabolic sensor AMPK (Figure 4A). The activa-
tion of Akt in the absence of AMPK activation is known to acti-
vate the mTOR pathway, contributing to colon inflammation
and cancer progression (Francipane and Lagasse, 2014).
Consistently, the colons of I/T mice showed, when compared
to controls, a lower activation of the mTOR pathway in
response to DSS treatment, as revealed by the lower phos-
phorylation of mTOR, p70S6K, and 4EBP1 (Figure 4A) and
the concurrent enhanced phosphorylation of raptor and
eIF4E proteins (Figure 4A). An increase in the expression of
the anti-apoptotic Bcl-xL protein in colons of I/T mice was
also observed, suggesting that it might contribute to the
DSS-resistant phenotype of these animals (Figure 4A). How-
ever, no relevant changes in the expression of other anti-1206 Cell Reports 19, 1202–1213, May 9, 2017apoptotic (Mcl-1 and Bcl-2) and auto-
phagy (p62) markers were observed
(Figure 4A).
In agreement with the promotion of an
anti-inflammatory phenotype in the colons
of I/T mice, despite the NFkB activation
observed in these animals (Figure 4B),
we observed a lesser activation of the
pro-inflammatory STAT3 (Figure 4B), and
of the pro-angiogenic and pro-invasive
CD31andCD14markers,when compared
to controls (Figure 4B). Additional markers
that emphasize the cell-protective role
afforded by the activation NFkB are the
maintenanceof theexpression of themito-chondrial mitofusin 2, OPA1, and VDAC in the colons of I/T mice
(FigureS2), suggesting thepreservation ofmitochondrial integrity
in response to the inflammatory stress.
Priming Innate Immunity in I/T Mice
Macrophages are essential components of innate immunity and
play key roles in inflammation and disease (Osborn and Olefsky,
2012; Pollard, 2009). Hence, we investigated the inflammatory
response and potential polarization of macrophages in DSS-
treated animals (Figures 5A and S3). Immunofluorescence anal-
ysis of colon tissue slices from I/T and control mice highlighted
a significant infiltration of macrophages after DSS treatment in
both phenotypes (F4/80+ staining in Figures 5A and S3). We
did not observe the co-localization of the macrophage F4/80+
marker and Ki67 in the colons of mice after DSS (Figure S4A),
thus supporting that macrophages in the adult mouse intestine
do not proliferate and are replenished by recruitment of blood
Figure 5. IF1 Mediates Polarization of M2
Macrophages
(A) Immunofluorescence microscopy of macro-
phages in colons from control (CL) and I/T mice
treated or not treated with 2% DSS during 10 days.
Upper row: anti-F4/80 (macrophage marker,
green), iNOS (M1 macrophage and inflamed tissue
marker, red), and DAPI (nuclei, blue). Lower row:
anti-F4/80 (green), CD206 (M2 macrophages, red)
and DAPI (blue) in control (CL) and I/T mice. Scale
bars, 50 mm. (In smaller panels: scale bars, 10 mm).
Individual panels are shown in Figure S3. Histo-
grams show the quantification of the total number
(F4/80+), M1 (F4/80+/iNOS+), and M2 (F4/80+/
CD206+) macrophages per field, respectively. Er-
ror bars represent the mean ± SEM of ten fields per
condition.
(B) Percent changes in the levels of the anti-in-
flammatory cytokines IL-4 and IL-10 and in pro-
inflammatory cytokines IL-6 and G-CSF in plasma
from control (CL, closed bars) and I/T (open bars)
mice after 10 days of 2% DSS administration. The
data shown indicate the mean ± SEM of seven
animals per group.
(C) Immunohistochemistry of colon from control
(CL) and I/T mice treated or not treated with 2%
DSS during 10 days. Colon slices were stained with
anti-IL-6 or anti-IL-10. Scale bars, 50 mm. Arrows
indicate positive cells.
Histograms show the number of positive cells per
squaremillimeter in 12 colon slices per condition. In
(A) and (B), *p < 0.05, when compared to CL by
Student’s t test; #p < 0.05, when compared to
CL + DSS by Student’s t test. In (C), *p < 0.05;
**p < 0.001, when compared to CL and DSS-
treated CL by Student’s t test, respectively.
See also Figures S3 and S4.monocytes (Bain et al., 2014). In colons of control DSS-treated
mice, induced nitric oxide synthase (iNOS) expression was
augmented, and the infiltrating macrophages were almost all
of the M1 phenotype, as revealed by the co-localization of
F4/80+ and iNOS staining (Figures 5A and S3). Infiltrating M2
macrophages (F4/80+ and CD206+ cells) were very low in
control DSS-treated mice (Figures 5A and S3). Remarkably,
themajority of the colon-infiltratingmacrophages in DSS-treated
I/T mice were of the M2 phenotype, as revealed by the predom-
inant co-localization of F4/80+ and CD206+ staining (Figures 5A
and S3), whereas the number of F4/80+, iNOS+ cells was very
low (Figures 5A and S3). The lack of F4/80+ and IF1 co-localiza-
tion (Figure S4B) indicated that IF1 is not being expressed in
macrophages, excluding potential cell-extrinsic effects. Consis-
tent with these results, blood cytokines in response to DSS treat-
ment revealed enhanced levels of the anti-inflammatory IL-4 and
IL-10 (Figure 5B) and a significant reduction in pro-inflammatoryCellIL-6 and G-CSF (Figure 5B) in I/T mice
when compared to controls. Determina-
tion of IL-6- and IL-10-positive cells in
the colons of control and I/T mice treated
with DSS further confirmed the anti-
inflammatory phenotype of I/T mice(Figure 5C). Moreover, canonical discriminant analysis using
the expression of 17 relevant immune gene markers (Table S1),
as selected by the algorithm (B220, CCL2, CD206, CD4,
EGR1, NFKB1A, BCL2L1, FOS, CTLA4, ARG1, HMGB1, INHBA,
NOS2, IL-10, L13, IL-1b, and NFKB1), revealed that the samples
from the four experimental groups nicely clustered into four
significantly different groups (p = 0.005; Figure 6A).
In line with the anti-inflammatory phenotype of the colons of
I/T mice, we observed that CD4+ T cells were most significantly
recruited upon treatment with DSS in the colons of I/T mice
(Figure 6B). Interestingly, the recruitment of CD4+/FOXP3+
cells (Tregs), those that restrain inflammatory responses, was
also significantly augmented in the inflamed colons of I/T
mice when compared to those of controls (Figure 6C). Overall,
the findings support that the IF1-mediated inhibition of the
mitochondrial H+-ATP synthase in the intestine induces a
state of immune preconditioning favoring an anti-inflammatoryReports 19, 1202–1213, May 9, 2017 1207
Figure 6. IF1 Mediates the Recruitment of
Anti-inflammatory Treg Cells
(A) Gene expression analysis of 46 markers of im-
mune cell populations, cytokines, and other im-
mune-regulatory and NFkB target genes in the
colons of CL and I/T mice treated or not treated
with DSS (see Table S1). Canonical discriminant
analysis using 17 of the genes selected by the al-
gorithm revealed that the samples from control (CL)
(1, blue), I/T (2, green), CL + DSS (3, red), and I/T +
DSS (4, purple) clustered into four different groups.
(B and C) Immunofluorescence microscopy of
T cells (CD4+) (B) and Tregs (CD4+/FOXP3+) (C) in
colons from control (CL) and I/T mice treated or not
treated with 2% DSS during 10 days. Colon slices
were stained with anti-CD4 (green), anti-FOXP3
(red), and DAPI (nuclei, blue). Scale bars, 80 mm in
(B) and 50 mm in (C); scale bar in inset, 10 mm.
Histograms show the number of positive cells per
field in 12 colon slices per condition. *p < 0.001,
when compared to CL+DSS by Student’s t test.
See also Table S1.phenotype of the tissue by recruiting M2 macrophages and
Treg cells.
QuenchingmtROSBlocks theAcquisition of theM2Anti-
inflammatory Phenotype
One potential link between the IF1-mediated decreased colon
inflammation in I/T mice is an elevation in mtROS production.
To investigate this in vivo, we administered themitochondria-tar-
geted antioxidant MitoQ to the mice orally as a MitoQ-b-cyclo-
dextrin adduct (Dashdorj et al., 2013). It should be noted that
the basal carbonylation of cellular proteins observed in colon ex-
tracts was significantly reduced after 10 days of MitoQ adminis-
tration both in control and in I/T mice (Figure 7A). In line with the
finding that MitoQ decreased oxidative stress, MitoQ adminis-
tration also inhibited the activation of the NFkB pathway in colon
extracts of I/T mice (Figure 7B) and abrogated the differences in
colon length between control and I/T mice after DSS-induced
colitis (Figure 7C). Likewise, histological analysis of the colon af-
ter DSS administration and MitoQ treatment revealed no differ-
ences between control and IF1-expressing mice (Figure 7D),
thus stressing the relevance of mtROS in promoting the pheno-
typic differences observed. Likewise, the administration of me-
salazine, an inhibitor of the NFkB pathway in inflamed intestinal
mucosa (Bantel et al., 2000), prevented the phosphorylation of
IkBa (Figure 7B) and essentially reproduced the effect of MitoQ
treatment in colon length (Figure 7C) and on the histological
change scores (Figure 7D). These findings further suggest that1208 Cell Reports 19, 1202–1213, May 9, 2017the metabolic preconditioning afforded
by inhibition of the ATP synthase involves
the production of mild-intensity mtROS,
which favors an anti-inflammatory pheno-
type that is effective when the tissue is
subsequently challenged with a stressing
insult that involves a major production of
ROS. In agreement with the aforemen-
tioned findings, the IF1-induced mediatedpolarization of colon macrophages to the M2 phenotype was
partially reverted to theM1 phenotype byMitoQ treatment, as re-
vealed by an enhanced iNOS+ staining in the colons of I/T mice
(Figure 7E), highlighting mtROS and the NFkB pathway as key
mediators in the anti-inflammatory phenotype.
DISCUSSION
Herein, we demonstrate that the expression of hIF1 in the colons
of transgenic mice partially inhibits the mitochondrial ATP syn-
thase and promotes the metabolic rewiring of the tissue to an
enhanced glycolytic phenotype. Inhibition of the ATP synthase
also guides a tissue homeostatic response through the activa-
tion of the NFkB pathway by generating the concurrent produc-
tion of mtROS. We show that the response to acute DSS-
induced colitis in control mice is highly aggressive, with elevated
plasma levels of the pro-inflammatory cytokines IL6 and G-CSF,
the activation of STAT3 and Akt/mTOR pathways, and the
functional polarization of tissue macrophages to the M1 pro-in-
flammatory phenotype. In sharp contrast to the expected pro-in-
flammatory role of the activation of NFkB in the intestine (Karin
and Greten, 2005), the response of transgenic mice to DSS-
induced colitis is less aggressive, showing enhanced plasma
levels of the anti-inflammatory IL4 and IL10 cytokines, decreases
of the pro-inflammatory IL6 cytokine, the activation of AMPK, the
polarization of tissue macrophages to the M2 anti-inflammatory
phenotype, and the enhanced recruitment of Treg cells that
Figure 7. mtROS Guide the IF1-Mediated
Protection from Inflammation
Control (CL) and I/T mice were treated or not
treated with the mtROS scavenger MitoQ-
b-cyclodextrin (MQ) or the NFkB inhibitor mesala-
zine (Mes).
(A) Representative blot of the extent of protein
carbonylation of colon extracts. Tubulin is shown
as loading control. The migration of molecular
mass markers is indicated at the left. Histograms
show the quantification of the carbonylation of p80
and p40 in CL (closed bars) and I/T (open bars)
mice treated or not treated with MQ.
(B) Representative blots of phospho-IkBa, IkBa,
and human IF1. Two samples per condition tested
are shown. Histograms show that expression of IF1
increases the p-IkBa/IkBa ratio in I/T (open bars)
when compared to CL (closed bars). MQ treatment
and Mes treatment prevent the phosphorylation of
IkBa.
(C) Colon length in control (CL, closed bars) and I/T
(open bars) mice not treated (None) or treated with
MQ, 2% DSS, 2% DSS + MQ, or 2% DSS + me-
salazine (DSS+Mes).
(D) H&E of colon slices from control (CL) and I/T
mice after treatment with 2% DSS in the absence
(None) or presence of MQ or mesalazine. Histo-
grams show the histologic change score in the
same conditions. The scale bar represents 50 mm.
(E) Immunofluorescence against F4/80 (green),
iNOS (red), and DAPI (blue) in control (CL) and I/T
mice after treatment with DSS in the absence or
presence of MQ. Scale bar, 50 mm. Histograms
show the total number (F4/80+), M1 (F4/80+/
iNOS+) and M2 (F4/80+/CD206+) macrophages
per field in colon slices from CL (closed bars) and
I/T (open bars) mice.
Error bars represent the mean ± SEM of five mice
per group. *p < 0.05, when compared to CL by
Student’s t test; #p < 0.05, when compared to CL +
DSS by Student’s t test; +p < 0.05, when compared
to I/T + DSS by Student’s t test.restrain inflammatory responses. In vivo, the mitochondria-tar-
geted antioxidant MitoQ obliterated the activation of NFkB and
its cellular protective effects after the induction of colon inflam-
mation, stressing the relevance of mitochondrial signaling in vivo
to the innate immune system of the tissue microenvironment.
Overall, these findings emphasize the potential role of the mito-
chondrial ATP synthase as a therapeutic target in inflammatory
and other related diseases.
In vitro findings have suggested a role for IF1 as a unidirec-
tional inhibitor of the ATP hydrolase activity of the mitochon-
drial ATP synthase (Walker, 2013), especially under conditions
of a compromised bioenergetic function of the organelle
(Campanella et al., 2008). However, as recently discussed in
detail (Formentini et al., 2014; Santacatterina et al., 2016),
findings in vivo have shown that IF1 overexpression exerts
inhibition of both the synthase activity and hydrolase activity
of the enzyme (Garcı´a-Bermu´dez et al., 2015). This contribu-tion, thus, adds an additional in vivo system arguing in the
same way.
Consistent with previous findings in cells in culture (Formentini
et al., 2012) and in neurons and hepatocytes of the transgenic
mice (Formentini et al., 2014; Santacatterina et al., 2016), we
observed that the overexpression of IF1 in the colon leads to
the carbonylation of some cellular proteins and promotes the
activation of the NFkB pathway. In addition, the IF1-mediated
signal can be quenched by MitoQ, a mitochondria-targeted anti-
oxidant. Together, these findings are consistent with an mtROS
signal, perhaps produced by reverse electron transfer at com-
plex I due to the elevation of the proton motive force that accom-
panies inhibition of the ATP synthase (Brand et al., 2004). How-
ever, as this signal is unable to significantly alter the cellular
redox state, it is of mild intensity. mtROS can promote the
activation of both the canonical and noncanonical NFkB path-
ways at various levels. We found that the IF1-mediated NFkBCell Reports 19, 1202–1213, May 9, 2017 1209
activation in the colon in vivo is exerted by the canonical
pathway, as revealed by the phosphorylation-dependent degra-
dation of the repressor IkBa, in agreement with previous findings
in colon cancer cells (Formentini et al., 2012). Despite the acti-
vation of NFkB, which is a master regulator of the inflamma-
tory response (Karin, 2006), we noted no relevant phenotypic
changes in hIF1-expressing mice when compared to control an-
imals. Phenotypic differences arouse only when I/T mice were
challenged with an acute cytotoxic stress. Similar situations
have been observed in models of neuronal excitotoxicity and
hepatotoxicity using transgenic mice that express the more
active IF1-H49K mutant (Formentini et al., 2014; Santacatterina
et al., 2016). Thus, these findings support that restraining the ac-
tivity of mitochondrial OXPHOS, specifically at the ATP synthase
level, affords a state of metabolic preconditioning of the tissue
that allows cells to withstand further deleterious insults, i.e., mi-
tohormesis (Chandel, 2015; Shadel and Horvath, 2015; Yun and
Finkel, 2014). Both genetic (Sun et al., 2014) and metabolic inhi-
bition of the ATP synthase (Chin et al., 2014; Fu et al., 2015) have
been shown to propitiate life extension in different organisms.
Interestingly, and as is shown in this study, common to these sit-
uations is the inhibition of themTOR pathway and the production
of mtROS via reverse electron transport, which are known to
extend animal lifespan (Chin et al., 2014; Scialo` et al., 2016).
Hence, we speculate that the mtROS-mediated activation of
the NFkB pathway plays a prominent role in the cellular adapta-
tions that facilitate mitohormesis.
As mentioned earlier, NF-kB signaling represents a key mech-
anism contributing to gut inflammation and colitis, acting as a
central mediator of pro-inflammatory cytokine and chemokine
production (Karin and Greten, 2005). To our surprise, but consis-
tent with recent findings that indicate a complex tissue-specific
role for the NF-kB pathway in inflammation (Greten et al., 2007;
Lawrence et al., 2001; Zhong et al., 2016), the IF1-mediated acti-
vation of this pathway in the colons of I/Tmice resulted in an anti-
inflammatory phenotype. Consistent with our findings, deletion of
negative regulators of the NFkB pathway leads to an increased
susceptibility to DSS-induced colitis (Garlanda et al., 2004; Lee
et al., 2000). Accordingly, we show that reducing the activation
of NFkB by the administration of mesalazine is sufficient to abro-
gate the IF1 anti-inflammatory effect. The activation of autophagy
has been shown to be involved in the anti-inflammatory effect of
NFkB (Criollo et al., 2010; Zhong et al., 2016). However, we found
no relevant changes in p62-guided mitophagy, suggesting that
the anti-inflammatory effect of NFkB in our model is exerted by
a different mechanism. The preconditioned tissue of transgenic
mice responded to DSS administration with a lesser activation
of the stress kinase TRIB3 and a diminished cell death, consistent
with the negative regulation that the kinase exerts on NFkB,
sensitizing cells to TNF- and TRAIL (TNF-related apoptosis-
inducing ligand)-induced apoptosis (Wu et al., 2003). Moreover,
whereas transgenic mice activated the metabolic stress kinase
AMPK in response to DSS-induced colitis, control mice activated
the pro-inflammatory and pro-oncogenic STAT3 and Akt/mTOR
pathways (Buettner et al., 2002; Francipane and Lagasse,
2014), suggesting that the colons of mice that overexpress hIF1
might be protected from cancer development, compared to con-
trol animals. These results might provide a mechanistic explana-1210 Cell Reports 19, 1202–1213, May 9, 2017tion to the finding that the overexpression of IF1 in human colon
carcinomas is associated with a better patient prognosis (Sa´n-
chez-Arago´ et al., 2013), while its overexpression in other carci-
nomas provides a marker of poor patient prognosis (Garcı´a-Ber-
mu´dez and Cuezva, 2016). Interestingly, the colons of I/T mice
showed a decreased STAT3 phosphorylation in the context of
increased IL6 and IL10. Since both cytokines trigger the phos-
phorylation of the transcription factor, we suggest that the
reduced phosphorylation of STAT3 in the colons of I/Tmicemight
result from the reduced oxidative damage experienced by these
animals in response to DSS. In fact, the phosphorylation of
STAT3 also depends on the activity of the protein phosphatase
Ptp1b, which is known to be inactivated by ROS (Meng et al.,
2002). This suggestion agrees well with the observed higher in-
duction of a potential Nrf-2-guided antioxidant response in the
colons of the pre-conditioned I/T mice.
Excessive ROS production causes tissue damage. However,
a mild ROS production represents a first line of defense against
microbial invasion (West et al., 2011), and its suppression
reduces innate immune responses (Break et al., 2012). Macro-
phages are tissue sentinels whose activation is pivotal in
restoring tissue integrity and function (Karin and Clevers,
2016). M1 (classically activated) macrophages produce inflam-
matory cytokines and nitric oxide and are considered more
inflammatory (Murray and Wynn, 2011). In contrast, M2 (alter-
natively activated) macrophages are involved in tissue repair
and are considered anti-inflammatory (Murray and Wynn,
2011). M1 and M2 macrophages also differ significantly in the
major pathways of energy provision (Mills and O’Neill, 2016)
with the adaptations in their mitochondrial respiratory chain
playing a relevant role in the antibacterial host defense (Ga-
raude et al., 2016). The source, site, and intensity of the ROS in-
fluence the regulation of macrophage signaling and polarization
(see Mills and O’Neill, 2016, for a recent review). It has been
recently shown that the inhibition of the mitochondrial electron
transport chain induces metabolic rewiring of macrophages
and controls inflammation by remodeling the Krebs cycle
(Lampropoulou et al., 2016). Moreover, other findings also sup-
port that lactate, the product of aerobic glycolysis, mediates
macrophage polarization from theM1 pro-inflammatory pheno-
type to the M2 anti-inflammatory phenotype (Colegio et al.,
2014). We observed that quenching mtROS production obliter-
ated the activation of NFkB, abolished the advantageous anti-
inflammatory phenotype, promoted the increased expression
of iNOS, and reduced the recruitment of M2 macrophages
or partially suppressed their polarization to the M2 phenotype
in the colons of transgenic mice. Since it is unlikely that MitoQ
could affect the cell metabolome or the rates of glycolysis
imposed by inhibition of the ATP synthase, we suggest that
the activation of the NFkB pathway by mtROS in the colons
of transgenic mice expressing hIF1 represents the basic mech-
anism that triggers a higher recruitment and/or polarization of
tissue macrophages to the M2 anti-inflammatory phenotype
in response to DSS-induced colitis.
Overall, the findings support that the mitochondrial ATP syn-
thase could represent a relevant target to promote macrophage




The pCMV-SPORT6-IF1 plasmid (ATCC) (Sa´nchez-Cenizo et al., 2010) con-
taining the human IF1 was PCR amplified, and the PCR product was assem-
bled into the pTRE2hyg vector (Clontech Laboratories) in the BamHI and
Notl restriction sites. The TRE2hyg-IF1 plasmid was digested with SexAI/
Drdl (New England Biolabs), and the 2.5-kb DNA fragment of interest was pu-
rified using the Elu-Quik DNA Purification Kit (Shleicher & Schuell). Transgenic
mice (TRE-IF1-47, I) were obtained by pronuclear microinjection of the
construct by the Servicio de Trangenesis of the CNB/CBMSO (UAM), using
standard protocols. Integration of the construct was confirmed by PCR (for-
ward, 50-CACAGAGTAGAGAACAACTG-30; reverse, 50-GTTAGTAGCACAC
AGACAAA-30). The Villin-rtTA2-M2 mice (T), expressing the transactivator
rtTA in intestinal epithelium (Roth et al., 2009) were used. The Tet-On dou-
ble-transgenic (I/T) animals were obtained by breeding I and T mice (Fig-
ure S5A). Animals were maintained on the C57/Bl6 genetic background. To
turn on the expression of IF1, 6-month-old double-transgenic mice were
administered doxycycline (2 mg/mL) in the drinking water during 15 days (Fig-
ure S5B). The same treatment was applied to littermate controls (genotypes
I, T, and wild-type) that do not express human IF1 (Figure S5B). Both male
and female control and I/T mice were used in the studies. Animal experiments
were carried out after approval of the institutional review board (Ethical Com-
mittee of the UAM, CEI-52-961) in compliance with animal policies and ethical
guidelines of the European Community.
Primary Cultures of Colonocytes
Mature non-dividing epithelial cells forming the colonic epithelium were ob-
tained as previously described (Booth and O’Shea, 2002).
Oxygen consumption rates in isolated colonocytes (500 mg protein) were
determined in a Clark-type electrode. TMPD-ascorbate (10 mM) was used
as a respiratory substrate in the presence or absence of 0.5 mM ADP, 6 mM
oligomycin, 5 mM FCCP, and 1 mM antimycin A.
The rates of lactate production were determined enzymatically, as previ-
ously reported (Sa´nchez-Cenizo et al., 2010).
Determination of the ATP Synthase Activity
Colonocytes resuspended in respiration buffer containing 1% Triton X-100
were used for the spectrophotometric determination of complex V activity,
as previously described (Barrientos et al., 2009).
Detection of Inflammatory Cytokines
For the determination of a panel of inflammatory cytokines, the Multi-Analyte
ELISArray Kit (QIAGEN) was used.
DSS-Induced Acute Colon Inflammation and Histology
Six-month-old control (n = 18) and I/T (n = 18) doxycycline-treated mice were
used (Figure S5B). To induce acute intestinal inflammation, 2% DSS was
added in the drinking water for 9 days (Wirtz et al., 2007) in the presence or
absence of the anti-inflammatory drug mesalazine (75 mg/kg/day) or the
mitochondrial scavengerMS-010 (MitoQwith b-cyclodextrin, 500 mM) simulta-
neously with doxycycline (Figure S5B). Determination of weight and examina-
tion of inflammation-associated rectal bleeding were conducted every day
for 10 days. Mice were sacrificed at day 10, and the colons were recollected.
Sections (30 mm thick) were taken in the coronal plane, stainedwith H&E for the
evaluation of the histological score (Wirtz et al., 2007), and processed for
immunohistochemistry or other analysis.
Western Blot and Analysis of Protein Carbonylation
Protein samples from colons or colonocytes were fractionated on SDS-PAGE.
Details of the antibodies used in western blots are provided in Supplemental
Information. For the determination of protein carbonylation, the Oxyblot
Oxidized Protein Detection Kit (Chemicon International) was used.
Immunohistochemistry
Colon antigens were retrieved by incubation in Dako Retrieval Solution (Dako
Cytomation) for 2 min at 98C. The anti-IF1 (1:50), anti-b-F1-ATPase (1:500),anti-IL10 (Abcam, 1:100), and anti-IL6 (Cell Signaling Technology, 1:20) anti-
bodies were used for immunohistochemistry using the peroxidase-based
EnVision FLEX Mini Kit, High pH (Dako Cytomation). Specimens were then
incubated with diaminobenzidine chromogenic substrate (Dako Cytomation)
for 5 min at room temperature. To assess the rate of cell death, the TUNNEL
Kit (Roche) was used.
Immunofluorescence and Confocal Microscopy
Colonocytes or colon slices were incubated with anti-b-catenin (Sigma, 1:500),
anti-vimentin (SantaCruzBiotechnology, 1:500), anti-F4/80 (BioLegend, 1:200),
anti-iNOS (BD Transduction Laboratories, 1:200), anti-CD206 (Bio-Rad, 1:200),
anti-activated caspase 3 (Cell Signaling Technology, 1:250), anti-Ki67 (Fisher
Scientific, 1:100), anti-CD4 (Abcam, 1:200), and anti-FOXP3 (eBioscience,
1:100). TOPRO or DAPI was used to identify nuclei. Secondary Cy-2/Cy-3/Cy-
5-conjugated antibodies were used (Millipore Bioscience Research Reagents).
Cellular fluorescence was analyzed by confocal microscopy. The area and in-
tensity of fluorescence were quantified by ImageJ software.
Statistical Analysis
Statistical analyses were performed using a two-tailed Student’s t test.
ANOVAs with post hoc Dunnett’s test were used for multiple comparisons to
the control, using the SPSS 17.0 software package. The results are indicated
as mean ± SEM. A p < 0.05 was considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2017.04.036.
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